Patient and disease characteristics in a small CAD cohort
Patient and disease characteristics in a small C
Patient and disease characteristics in a small C
Cold agglutinin disease: on the road to new insi
Targeted approaches in various B-cell malignanci
Changing paradigms in the management of mantle c
Optimizing timing, efficacy and tolerability in
Waldenström’s macroglobulinemia: BTK inhibition
Small-cell lung cancer: moving the limits furthe
Rare mutations: HER2, RET, ALK, BRAF DESTINY
COVID-19 in patients with thoracic cancers: TERA
Present and future perspectives of anti-angiogen